JP6294440B1 - Prefilled syringe - Google Patents

Prefilled syringe Download PDF

Info

Publication number
JP6294440B1
JP6294440B1 JP2016226677A JP2016226677A JP6294440B1 JP 6294440 B1 JP6294440 B1 JP 6294440B1 JP 2016226677 A JP2016226677 A JP 2016226677A JP 2016226677 A JP2016226677 A JP 2016226677A JP 6294440 B1 JP6294440 B1 JP 6294440B1
Authority
JP
Japan
Prior art keywords
chamber
plug body
main body
plug
rib
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016226677A
Other languages
Japanese (ja)
Other versions
JP2018082796A (en
Inventor
勝也 田口
勝也 田口
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MAEDA INDUSTRY CO., LTD.
Original Assignee
MAEDA INDUSTRY CO., LTD.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAEDA INDUSTRY CO., LTD. filed Critical MAEDA INDUSTRY CO., LTD.
Priority to JP2016226677A priority Critical patent/JP6294440B1/en
Application granted granted Critical
Publication of JP6294440B1 publication Critical patent/JP6294440B1/en
Publication of JP2018082796A publication Critical patent/JP2018082796A/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Abstract

【課題】バイパス付プレフィルドシリンジの薬剤と薬液の混合溶解時の液の過剰な噴出及び液漏れを防止する。【解決手段】この発明は、筒状の本体1内に第1成分と第2成分をそれぞれ収容する前室6と後室7を形成し、該前室6と後室7は本体1内に挿入され、その内周面に弾力的に押接されて周方向の複数条のリブRを形成した栓体3によって仕切られ、上記本体1の内周面には上記栓体3の通過時に前室6と後室7を連通させるバイパス13を凹設したプレフィルドシリンジにおいて、上記リブRが前記栓体3の後端以外の前側外周に本体1の内径D0を越える外径D1を備えた標準リブR1と、栓体3の後端外周に上記内径D0以上であって標準リブR1の外径D1未満の外径D2に形成された高圧解放用の端部リブR2とを備えてなることを特徴としている。【選択図】図3An object of the present invention is to prevent excessive ejection and leakage of liquid during mixing and dissolution of a drug and a chemical solution in a prefilled syringe with bypass. In the present invention, a front chamber 6 and a rear chamber 7 for accommodating a first component and a second component, respectively, are formed in a cylindrical main body 1, and the front chamber 6 and the rear chamber 7 are formed in the main body 1. It is inserted and partitioned by a plug body 3 that is elastically pressed against the inner peripheral surface thereof to form a plurality of circumferential ribs R, and the inner peripheral surface of the main body 1 is in front when the plug body 3 passes through. In the prefilled syringe having a recess 13 for communicating the chamber 6 and the rear chamber 7, the rib R has an outer diameter D1 exceeding the inner diameter D0 of the main body 1 on the front outer periphery other than the rear end of the plug 3. R1 and a high-pressure release end rib R2 formed on the outer periphery of the rear end of the plug body 3 with an outer diameter D2 which is equal to or larger than the inner diameter D0 and less than the outer diameter D1 of the standard rib R1. It is said. [Selection] Figure 3

Description

この発明は例えば粉末薬剤と薬液を予めシリンジ内の前室と後室の2室に収容し、使用時に内部のガスケット(栓体)を押圧移動させることにより、バイパスを介して後室の薬液を粉末を収容した前室に送り込み、両者を混合して溶液化して注射液として用いるプレフィルドシリンジに関する。   In this invention, for example, a powder medicine and a chemical solution are stored in advance in two chambers, a front chamber and a rear chamber in a syringe, and a chemical solution in the rear chamber is passed through a bypass by pressing and moving an internal gasket (plug) at the time of use. The present invention relates to a prefilled syringe that is fed into a front chamber containing powder, mixed into a solution, and used as an injection solution.

従来上記のようなバイパス付きのプレフィルドシリンジとして特許文献1,同2に示すものが公知であり、これらはいずれも加圧により後室の薬液がバイパスを介して前室に噴出する際に、噴出液がその強い勢いにより、前室よりさらに前方の溶液取出室に漏出するとともに、シリンジ先端に装着した注射針に到達して外部に漏出するのを防止するものである。   Conventionally, the prefilled syringes with bypass as described above are known in Patent Documents 1 and 2, both of which are ejected when the chemical solution in the rear chamber is ejected to the front chamber through the bypass by pressurization. Due to its strong momentum, the liquid leaks into the solution take-out chamber further forward from the front chamber, and prevents the liquid from reaching the injection needle attached to the tip of the syringe and leaking outside.

この内特許文献1の発明は前室6と後室7の間を仕切り、前方移動によりバイパス1aを開いて両室を連通させるガスケット(栓体)を2分割して形成し、両ガスケット51,52の隣接リブ間に軸方向リブ64,65,86,87を形成し、前側ガスケット51の前端側外周に環状凹部59,60を連通させる軸方向溝70,71を形成して、バイパス1aによる後室から前室への薬液の噴出の勢いを緩和させるものである。   In the invention of Patent Document 1, the front chamber 6 and the rear chamber 7 are partitioned, and a gasket (plug body) that opens the bypass 1a and communicates the two chambers by moving forward is divided into two, and both gaskets 51, The axial ribs 64, 65, 86, 87 are formed between the adjacent ribs 52, and the axial grooves 70, 71 for communicating the annular recesses 59, 60 are formed on the outer periphery on the front end side of the front gasket 51, and the bypass 1 a is used. The momentum of the ejection of the chemical solution from the rear chamber to the front chamber is reduced.

また特許文献2の発明は、シリンジ内でミドル栓体7がバイパス14の後端に達した時の第1室の一部とフロント栓体6を含む容積VSを、液体成分の体積VC以下75%以上として、後室から前室への薬液の強い勢いの噴出を緩和するものである。   In the invention of Patent Document 2, the volume VS including a part of the first chamber and the front plug 6 when the middle plug 7 reaches the rear end of the bypass 14 in the syringe is equal to or less than the volume VC of the liquid component 75. % Or more to relieve the strong momentum of the chemical solution from the rear chamber to the front chamber.

特開2002−263186号公報JP 2002-263186 A 特許第4884769号公報Japanese Patent No. 4884769

しかし上記特許文献1のシリンジガスケットは、前室と後室を仕切る栓体(ガスケット)を2分割して成形することや、栓体外周に複雑な通路を形成する必要がある等、ガスケットの形状や構造が複雑で全体として高コストとなり品質管理もより高度なものが要求されるほか、微細な流路は目詰まり等の事故を伴い易いという欠点がある。   However, the syringe gasket of the above-mentioned Patent Document 1 has a shape of gasket such as a plug body (gasket) that divides the front chamber and the rear chamber divided into two parts, and a complicated passage needs to be formed on the outer periphery of the plug body. In addition to the complexity of the structure and high cost as a whole, higher quality control is required, and the fine flow path has the disadvantage of being easily accompanied by accidents such as clogging.

特許文献2のシリンジは、ある流動的条件下でのシリンジ内の一部と栓体との合計容積VSや、後室内に収容する液体の体積VCとの相対的数値を算出して計算するものであり、例えば液体(薬液)の量は粉末状薬剤の量や質との関係で決められ、技術的要素が不安定であり、この発明のシリンジの品質管理も不安定な要素を含むという欠点がある。   The syringe of Patent Document 2 calculates and calculates a relative numerical value of the total volume VS of a part of the syringe and the stopper body under a certain fluid condition and the volume VC of the liquid accommodated in the rear chamber. For example, the amount of liquid (medical solution) is determined in relation to the amount and quality of the powdered drug, the technical elements are unstable, and the quality control of the syringe of the present invention also includes unstable elements. There is.

上記のような課題を解決するための本発明のプレフィルドシリンジは、第1に筒状の本体1内に第1成分14と第2成分16をそれぞれ収容する前室6と後室7を形成し、該前室6と後室7は、上記本体1内に挿入され、上記本体1の内周面に弾力的に押接されて周方向の複数条のリブRを形成した栓体3によって仕切られ、上記本体1の内周面には上記栓体3の通過時に前室6と後室7を連通させるバイパス13を凹設したプレフィルドシリンジにおいて、上記リブRが前記栓体3の後端以外の前側外周に本体1の内径D0を越える外径D1を備えた標準リブR1と、栓体3の後端外周に上記内径D0以上であって標準リブR1の外径D1未満の外径D2に形成された高圧解放用の端部リブR2とを備え、該端部リブR 2 の軸心に沿った断面がアングル状の山形に形成されるとともに、後側の周面が軸心に向って傾斜するテーパー面に形成されることを特徴としている。 The prefilled syringe of the present invention for solving the above-mentioned problems is formed by first forming a front chamber 6 and a rear chamber 7 for accommodating a first component 14 and a second component 16 in a cylindrical main body 1, respectively. , front chamber 6 and the rear chamber 7 is inserted into the body 1, the partition by stopper 3 formed ribs R of plural rows circumferential direction is resiliently pressed against the inner peripheral surface of the main body 1 In the prefilled syringe in which a bypass 13 is provided in the inner peripheral surface of the main body 1 so as to allow the front chamber 6 and the rear chamber 7 to communicate with each other when the plug body 3 passes, the rib R is other than the rear end of the plug body 3. outer diameter D 1 of the the standard rib R 1 having an outer diameter D 1 exceeds the internal diameter D 0 of the main body 1 in the front outer periphery, there is the internal diameter D 0 or the rear end outer periphery of the plug 3 of the standard rib R 1 less than an outer diameter and a end ribs R 2 for high pressure release formed in the D 2, cross-section a along the axis of the end portion rib R 2 Is formed in a guru-shaped chevron, the peripheral surface of the rear side is being formed into a tapered surface inclined towards the axis.

に、標準リブR1の断面が円弧状の山形に形成されたことを特徴としている。 Second , the standard rib R 1 is characterized in that the cross section is formed in an arcuate chevron.

に、前室6と後室7間を仕切る栓体を中栓体3とし、前室6の前方に中栓体3の前方移動により加圧されて前方に移動することにより第1成分14と第2成分16の溶解液を本体1の外部に吐出させる前栓体2を設け、上記中栓体3の前端面を山形に突出させて形成し、上記前栓体2の後端面を中栓体3の前端と重なり合って適合するように凹状に陥没させて形成したことを特徴としている。 Third, the first component by moving the plug member for partitioning between the front chamber 6 and the rear chamber 7 and Chusentai 3, pressurized forward by forward movement of Chusentai 3 in front of the front chamber 6 14 and the front plug body 2 that discharges the solution of the second component 16 to the outside of the main body 1 is formed by projecting the front end face of the inner plug body 3 in a mountain shape, and the rear end face of the front plug body 2 is formed. It is characterized in that it is formed in a concave shape so as to overlap and fit with the front end of the inner plug body 3.

以上のように構成される本発明のプレフィルドシリンジは、シリンジ後端側からの押圧によって前室、後室を仕切る栓体の端部リブが同室間のバイパスの後端を通過する際の後室の内圧が、端部リブの後側周面の傾斜(テーパー)面によって徐々に且つ緩やかにバイパス内及び前室内に解放されるので、栓体の従来の標準リブが押接されて移動している時の後室の高い内圧から瞬時に解放されるよりも、後室の薬液の噴出の勢いが緩和され、薬液がバイパスを介して強力な勢いで前室内に未混合・未溶解のまま噴出されることによる、前方の溶液取出室やさらには先端の注射針からの噴出等の問題が解決される利点がある。   The prefilled syringe of the present invention configured as described above is a rear chamber when the end rib of the plug body that partitions the front chamber and the rear chamber passes through the rear end of the bypass between the chambers by pressing from the syringe rear end side. Since the internal pressure of the end rib is gradually and gently released into the bypass and the front chamber by the inclined (tapered) surface of the rear peripheral surface of the end rib, the conventional standard rib of the plug body is pushed and moved. Rather than being released instantly from the high internal pressure of the rear chamber, the momentum of the liquid ejection of the rear chamber is reduced, and the liquid chemical is ejected into the front chamber with a strong momentum through the bypass without being mixed or undissolved. By doing so, there is an advantage that problems such as ejection from the front solution take-out chamber and the injection needle at the tip are solved.

また単に栓体の後端のリブの形状や寸法を標準リブの高さ未満の高さにし、さらにアングル状の頂点を有する山形に形成することにより、バイパス後端の通過時に、後室の内圧による端部リブの変形が早い時期から徐々に行われ且つバイパスへの薬液の流路が、端部リブのテーパー面により徐々に広くなる結果、後室内の圧力も徐々に且つ緩やかに解放される。   In addition, by simply setting the rib shape and dimensions of the rear end of the plug body to a height less than the height of the standard rib, and forming it into a mountain shape having an angled apex, the internal pressure of the rear chamber is passed when the bypass rear end passes. The end rib is gradually deformed by an early stage, and the flow path of the chemical liquid to the bypass is gradually widened by the taper surface of the end rib. As a result, the pressure in the rear chamber is gradually and gradually released. .

さらに、内部の空洞部や流量の容積比を設定する必要もなく、前栓体の挿入位置を本体の先端側にすることができ、これを後位置にすることによる全体の押出し操作時の摺動抵抗の増大を避けることができる。   Furthermore, there is no need to set the internal cavity and the volume ratio of the flow rate, and the insertion position of the front plug can be set to the front end side of the main body. An increase in dynamic resistance can be avoided.

しかも後端リブを上記のように構成する単純な技術要素のみで上記圧力解放ができるので、形状や構造も簡単で低コストであるほか、作動も確実であるという利点がある。   In addition, since the pressure can be released only by a simple technical element that constitutes the rear end rib as described above, there are advantages that the shape and structure are simple and low cost, and the operation is reliable.

その他特許文献1の技術のように形状構造の複雑化、高コスト化を招くこともなく、特許文献2の技術のように、薬液量等の流動的要素を技術的要素にしないため、設定やメンテナンスもより容易である。   Other than the technology of Patent Document 1, the shape structure is not complicated and the cost is not increased, and the fluid element such as the amount of the chemical solution is not used as a technical element as in the technology of Patent Document 2. Maintenance is also easier.

その他中栓体の先端を山形にし、前栓体の後端をその山形と適合し合う凹状に形成することにより、前室内での薬液と粉末剤の混合・溶解を容易にすることができるほか、注射時の薬液の残量を確実に減らすことができる。   In addition, it is possible to facilitate mixing and dissolution of chemicals and powders in the front chamber by forming the tip of the inner plug into a chevron and forming the rear end of the front plug in a concave shape that matches the chevron. The remaining amount of the chemical at the time of injection can be surely reduced.

本発明のシリンジの押動操作前の状態を示す全体断面図である。It is a whole sectional view showing the state before pushing operation of the syringe of the present invention. シリンジの押動操作中の中栓体がバイパスを通過する状態を示す要部断面図である。It is principal part sectional drawing which shows the state in which the inside plug body during pushing operation of a syringe passes a bypass. 上記要部断面図の一部拡大断面図である。It is a partially expanded sectional view of the said principal part sectional drawing.

図1〜4は本発明の1実施例を示し、図1に示すように本発明のシリンジは前後長約85mm程度で、内径10.5mmの透明なガラス又はプラスチック製の円筒状の本体1に対し、前端と後端及び中間部には、弾力性を備えたゴム又はプラスチック材よりなる前栓体2,中栓体3,後栓体4が、それぞれ左右動自在に且つ気密性を保持して嵌合され、中栓体3によって前室6と後室7が形成されている。   1 to 4 show an embodiment of the present invention. As shown in FIG. 1, the syringe of the present invention has a longitudinal length of about 85 mm and a transparent glass or plastic cylindrical body 1 with an inner diameter of 10.5 mm. On the other hand, the front plug body 2, the middle plug body 3 and the rear plug body 4 made of rubber or plastic material having elasticity are respectively movable at the front end, the rear end, and the middle portion so that they can move left and right and are airtight. The front chamber 6 and the rear chamber 7 are formed by the inner plug body 3.

本体1の開放された前端には筒状の針取付キャップ8が嵌合固着され、その先端側中央に注射針(図示しない)を着脱可能に取付けるボス部8aを形成し、その外側に注射針の保護キャップ(図示しない)の基端部を挿脱可能に挿入するキャップ取付部8bが形成されている。針取付キャップ8の後側には筒状の前後2段の周壁を形成しており、その前半部は前記前栓体2がシリンジ本体1の前端より押出された際にこれを受け取るとともに、ここに流入した薬剤溶液をボス部8aを介して注射針に送り出す取出室8cが形成されている。   A cylindrical needle mounting cap 8 is fitted and fixed to the opened front end of the main body 1, and a boss portion 8 a for removably mounting an injection needle (not shown) is formed at the center of the distal end side. A cap mounting portion 8b is formed to insert a base end portion of the protective cap (not shown) in a detachable manner. A cylindrical front and rear two-stage peripheral wall is formed on the rear side of the needle mounting cap 8, and the front half receives the front plug body 2 when it is pushed out from the front end of the syringe body 1. An extraction chamber 8c is formed through which the drug solution that has flowed into the tube is sent to the injection needle through the boss portion 8a.

さらにその後端側には本体1の開放された前端の外周に嵌着されるカラー部8dが一体的に連設されている。前記取出室8cの内周にはここに前栓体2が押出し収容された際にその内周と前栓体2の外周との間には、注射液(薬剤溶液)を前方に通過させる通路を形成するための凹溝、前栓体2を支持するためのリブ8e等が設けられている。   Further, a collar portion 8d fitted to the outer periphery of the opened front end of the main body 1 is integrally provided on the rear end side. A passage through which an injection solution (drug solution) passes forwardly between the inner periphery and the outer periphery of the front plug body 2 when the front plug body 2 is extruded and accommodated in the inner periphery of the extraction chamber 8c A groove for forming the rib, a rib 8e for supporting the front plug body 2, and the like are provided.

本体1の開放端となっている後端外周にはフランジ状の鍔部9が突設され、該鍔部9には注射操作時に上下で2本の指を掛ける指掛け11が着脱可能に取付けられている。また後栓体4の後端中央には注射操作時に後栓体4を内部に押込むためのロッド12(押し子)の前端がねじ込み固定されており、ロッド12は図示するように十字形の断面で一定間隔毎に円形の補強プレート12aが一体的に形成されている。   A flange-like collar 9 protrudes from the outer periphery of the rear end, which is the open end of the main body 1, and a finger hook 11 that hangs two fingers up and down during the injection operation is detachably attached to the collar 9. ing. In addition, the front end of a rod 12 (presser) for pushing the rear plug body 4 into the interior thereof at the time of injection operation is screwed and fixed at the center of the rear end of the rear plug body 4, and the rod 12 has a cross-shaped cross section as shown in the figure. Circular reinforcing plates 12a are integrally formed at regular intervals.

シリンジの筒状本体1の前後の中心よりやや前寄り位置で中栓体3の通過位置の内面には、中栓体3の円柱形外周部分の長さよりやや長い軸方向全長を有する溝状のバイパス13が凹設されている。前室6内には溶解されるべき粉末状の薬剤(第1成分)14が、後室7内には上記薬剤14を溶解する蒸留水その他の薬液(第2成分)16が予め収容されており、この構造のものは全体としてバイパス付のプレフィルドシリンジとして知られている。   A groove-like shape having an axial total length slightly longer than the length of the cylindrical outer peripheral portion of the inner plug body 3 on the inner surface of the passage position of the inner plug body 3 at a position slightly forward of the front and rear centers of the cylindrical main body 1 of the syringe. A bypass 13 is recessed. A powdery drug (first component) 14 to be dissolved is accommodated in the front chamber 6, and distilled water or other chemical solution (second component) 16 for dissolving the drug 14 is accommodated in the rear chamber 7 in advance. This structure is known as a prefilled syringe with a bypass as a whole.

上記プレフィルドシリンジは、予め注射針用のキャップを取外して図1の状態からロッド12の後端部を押して後栓体4を本体1内に押込むと、後室7への加圧によって中栓体3が本体1内を前進移動し、中栓体3が図2,図3に示すようにバイパス13に差掛かり且つその外周後端がバイパス13の後端部を通過する際に、後室7の薬液16がバイパス13を介して前室6内に流入し、薬剤14と混合され、溶解させる。この溶解を確認後さらにロッド12を押込んで中栓体3を前進させると、前栓体2が取出室8c内に押出されて、溶解液(注射液)は前栓体2の外周に形成された流路を介して注射針に至る。   In the prefilled syringe, when the cap for the injection needle is removed in advance and the rear end portion of the rod 12 is pushed into the main body 1 from the state shown in FIG. When the body 3 moves forward in the main body 1, the inner plug body 3 reaches the bypass 13 as shown in FIGS. 2 and 3, and the rear end of the outer periphery passes the rear end of the bypass 13. 7 chemical solution 16 flows into the anterior chamber 6 through the bypass 13 and is mixed with the drug 14 to be dissolved. After confirming this dissolution, when the rod 12 is pushed further to advance the inner plug body 3, the front plug body 2 is pushed into the take-out chamber 8c, and a solution (injection solution) is formed on the outer periphery of the front plug body 2. To the injection needle through the flow path.

既述のように従来のバイパス付プレフィルドシリンジでは、中栓体3の外周の後端がバイパス13の後端を通過する際に、ロッド12の押圧力が強いと後室7内の薬液16に加わる圧力が高過ぎて、バイパス13から前室6内に噴出する薬液の勢い(運動エネルギー)が強くなり、前栓体2を押出し、取出室8cを介して注射針より漏出する等の問題がある。このため、本発明はこの問題を解決するため中栓体3を以下に述べるように構成するものである。   As described above, in the conventional prefilled syringe with bypass, when the rear end of the outer periphery of the inner plug body 3 passes the rear end of the bypass 13, if the pressing force of the rod 12 is strong, the chemical solution 16 in the rear chamber 7 is applied. Since the applied pressure is too high, the momentum (kinetic energy) of the chemical liquid ejected from the bypass 13 into the front chamber 6 is increased, and the front plug body 2 is pushed out and leaks from the injection needle through the extraction chamber 8c. is there. For this reason, in the present invention, in order to solve this problem, the inner plug body 3 is configured as described below.

図1〜図3に示すように各栓体2〜4の外周には、標準的な形状である円弧状の山形断面で周方向の複数本(本例では3本)のリブRが形成され、リブRの間には円弧状の谷形断面の溝Gがそれぞれ形成されている。この例ではシリンジ本体1の内径D0が10.5mmであるのに対し、各栓体2〜4のリブRの外径D1が約10.9mm、溝Gの外径D3が10.1mmであり、本体1に挿入嵌合した場合、上記リブRと溝Gが弾力的に変形して圧接することにより、本体1の内周面とのシール性(保密性)が保持される。 As shown in FIGS. 1 to 3, a plurality of (three in this example) ribs R in the circumferential direction are formed on the outer circumferences of the plugs 2 to 4 in a circular arc-shaped cross section that is a standard shape. Between the ribs R, grooves G each having an arcuate valley-shaped cross section are formed. In this example, the inner diameter D 0 of the syringe body 1 is 10.5 mm, whereas the outer diameter D 1 of the rib R of each plug 2 to 4 is about 10.9 mm, and the outer diameter D 3 of the groove G is 10.4 mm. When it is 1 mm and is inserted and fitted into the main body 1, the rib R and the groove G are elastically deformed and brought into pressure contact with each other, so that the sealing performance (tightness) with the inner peripheral surface of the main body 1 is maintained.

そして本実施例ではバイパス13部分を通過する中栓体3のリブRは、前方側3本を標準的な円弧状の断面形状とした標準リブR1と、最後端のリブを図示するようにアングル状(又は逆V字形)の頂点を有する山形断面に形成した端部リブR2とにより構成されている。そして端部リブR2の前面はその直前の円弧状の溝部の前後中央(谷底)に向って本体1の軸心に対して直角方向に形成されており、後面(外周面)は軸心に対して緩やかな鋭角の傾斜θ(15°前後)に傾斜するテーパー面を、例えば0.8〜1.2mmの長さで形成している。図3では、上記端部リブR2の直前に形成されたV字形の溝を、他の標準的な円弧状の溝G1に対し、端部溝G2として表わした。上記端部リブR2の外径D2は本体1の内径D0と同一か僅かに大きく形成されている。この例では中栓体3の後端部外径D4は10.1mmに形成され、溝G1,G2の外径D3と同一に形成されている。 In the present embodiment, the rib R of the inner plug body 3 that passes through the bypass 13 portion is shown as a standard rib R 1 having three standard arcuate cross sections on the front side and a rearmost rib. is constituted by the end ribs R 2 formed in the chevron cross-section with an apex angle-shaped (or reverse V-shape). The front surface of the end rib R 2 is formed in a direction perpendicular to the axial center of the main body 1 toward the front and rear center (valley bottom) of the arc-shaped groove immediately before the end rib R 2 , and the rear surface (outer peripheral surface) is the axial center. On the other hand, the taper surface which inclines to gentle acute angle inclination (theta) (around 15 degrees) is formed, for example with the length of 0.8-1.2 mm. In Figure 3, the V-shaped groove formed in the immediately preceding end ribs R 2, relative to the groove G 1 of other standard arcuate, expressed as an end groove G 2. The outer diameter D 2 of the end rib R 2 is the same as or slightly larger than the inner diameter D 0 of the main body 1. In this example, the outer diameter D 4 of the rear end portion of the inner plug body 3 is 10.1 mm, which is the same as the outer diameter D 3 of the grooves G 1 and G 2 .

この構造により、中栓体3がロッド12による加圧によって前進する際、図3,図4に示すように端部リブR2の外周端がバイパス13の後端位置を通過する時、後室7の内圧により薬液16は、端部リブR2の後方周面である傾斜したテーパー面に沿って案内され、アングル状の端部リブR2の外周端を弾力的に変形させながらバイパス13内に比較的緩やかに流れ込み、前室6に流出する。 This structure, when upon Chusentai 3 is advanced by pressure applied by the rod 12, Figure 3, outer peripheral edge of the end ribs R 2 as shown in FIG. 4 through the rear end position of the bypass 13, the rear chamber chemical 16 by 7 internal pressure of the can is guided along the inclined taper surface is a rear peripheral surface of the end ribs R 2, while the outer peripheral end of the angled edge ribs R 2 is resiliently deformed bypass 13 Flows relatively slowly into the front chamber 6.

この時、端部リブRは標準リブRに比して本体1の内周面への接触圧も低く且つ接触面も少ないために、中栓体3の後端がバイパス13の後端に達する前であっても、後室7内の圧力が比較的低い状態で弾性変形してバイパス13内に薬液を送り出すことによって、さらに中栓体3の端部リブRの後部周面と本体1の内周面との隙間がテーパー状に徐々に広くなっている。このため前室6内への薬液16の流入量が徐々に増えることになり、急激な流入による薬液の強い勢いでの噴出を防止することができる。 At this time, since the end rib R 2 has a lower contact pressure to the inner peripheral surface of the main body 1 and a smaller contact surface than the standard rib R 1 , the rear end of the inner plug body 3 is the rear end of the bypass 13. Even before the pressure reaches, the elastic deformation of the rear chamber 7 is relatively low and the chemical solution is fed into the bypass 13 to further reduce the rear peripheral surface of the end rib R 2 of the inner plug body 3. The gap with the inner peripheral surface of the main body 1 is gradually increased in a tapered shape. For this reason, the inflow amount of the chemical liquid 16 into the front chamber 6 is gradually increased, and it is possible to prevent the chemical liquid from being ejected with a strong momentum due to the rapid inflow.

また、上記中栓体3の前端面は円錐形の山形に突出形成されており、これに対して中栓体3の前面と重なり合う前栓体2の後面は、上記中栓体3の前面と密着して重なり合うように擂り鉢状の凹部に形成されている。この機構により、両栓体2,3が重なり合うと上記凹凸面の密着により注射液が前室6内に残存することなく排出される利点がある。   Further, the front end surface of the inner plug body 3 is formed so as to project into a conical mountain shape. On the other hand, the rear surface of the front plug body 2 overlapping the front surface of the inner plug body 3 is connected to the front surface of the inner plug body 3. It is formed in a bowl-shaped recess so as to closely overlap. With this mechanism, there is an advantage that the injection solution is discharged without remaining in the front chamber 6 due to the close contact of the uneven surface when the plug bodies 2 and 3 overlap each other.

その他前栓体2の前面、中栓体3の後面、後栓体4の前後の各面には、他の面と押接された時に互いに密着して付着し合わないための微小な突起部17がそれぞれ突設されている。18a,18bはそれぞれ中栓体3と後栓体4の作用位置又は停止位置の目安とするために、本体1の周面に帯状に印刷表示する表示ラインの位置を示している。   Other minute projections on the front surface of the front plug body 2, the rear surface of the inner plug body 3, and the front and rear surfaces of the rear plug body 4 so as not to adhere and adhere to each other when pressed against other surfaces Reference numerals 17 are provided in a protruding manner. Reference numerals 18a and 18b denote positions of display lines that are printed and displayed in a strip shape on the peripheral surface of the main body 1 in order to provide a guide for the action position or stop position of the inner plug body 3 and the rear plug body 4, respectively.

1 (シリンジ)本体
2 前栓体
3 中栓体(栓体)
4 後栓体
6 前室
7 後室
8 針取付キャップ
12 ロッド
13 バイパス
14 薬剤(第1成分)
16 薬液(第2成分)
本体内径
標準リブ外径
端部リブ外径
R リブ
標準リブ
端部リブ
1 (Syringe) body 2 Front plug body 3 Medium plug body (plug body)
4 Rear plug body 6 Front chamber 7 Rear chamber 8 Needle mounting cap 12 Rod 13 Bypass 14 Drug (first component)
16 chemical (second component)
D 0 Body inner diameter D 1 Standard rib outer diameter D 2 End rib outer diameter R Rib R 1 Standard rib R 2 End rib

Claims (3)

筒状の本体(1)内に第1成分(14)と第2成分(16)をそれぞれ収容する前室(6)と後室(7)を形成し、該前室(6)と後室(7)は、上記本体(1)内に挿入され、上記本体(1)の内周面に弾力的に押接されて周方向の複数条のリブ(R)を形成した栓体(3)によって仕切られ、上記本体(1)の内周面には上記栓体(3)の通過時に前室(6)と後室(7)を連通させるバイパス(13)を凹設したプレフィルドシリンジにおいて、上記リブ(R)が前記栓体(3)の後端以外の前側外周に本体(1)の内径(D0)を越える外径(D1)を備えた標準リブ(R1)と、栓体(3)の後端外周に上記内径(D0)以上であって標準リブ(R1)の外径(D1)未満の外径(D2)に形成された高圧解放用の端部リブ(R2)とを備え、該端部リブ(R 2 )の軸心に沿った断面がアングル状の山形に形成されるとともに、後側の周面が軸心に向って傾斜するテーパー面に形成されるプレフィルドシリンジ。 A front chamber (6) and a rear chamber (7) for accommodating the first component (14) and the second component (16), respectively, are formed in the cylindrical main body (1), and the front chamber (6) and the rear chamber are formed. (7) is inserted into the main body (1) within the plug forming the body (1) is resiliently pressed against the inner peripheral surface of the circumferential direction of the plural rows of ribs (R) (3) In the prefilled syringe in which a bypass (13) for communicating the front chamber (6) and the rear chamber (7) is recessed on the inner peripheral surface of the main body (1) when passing through the plug (3), A standard rib (R 1 ) in which the rib (R) has an outer diameter (D 1 ) exceeding the inner diameter (D 0 ) of the main body (1) on the front outer periphery other than the rear end of the plug (3); body ends for pressure release, which is formed on an outer diameter less than the outer diameter (D 1) (D 2) of the rear periphery to the inside diameter (D 0) Exceeded by standard ribs (R 1) (3) ribs (R 2 With the door, prefilled the cross section along the axis of the end ribs (R 2) is is formed in a chevron angle-shaped, the peripheral surface of the rear side is formed in a tapered surface inclined towards the axis Syringe. 標準リブ(R1)の断面が円弧状の山形に形成された請求項に記載のプレフィルドシリンジ。 Prefilled syringe according to claim 1, the cross section of the standard ribs (R 1) is formed in a circular arc shape of the chevron. 前室(6)と後室(7)間を仕切る栓体を中栓体(3)とし、前室(6)の前方に中栓体(3)の前方移動により加圧されて前方に移動することにより第1成分(14)と第2成分(16)の溶解液を本体(1)の外部に吐出させる前栓体(2)を設け、上記中栓体(3)の前端面を山形に突出させて形成し、上記前栓体(2)の後端面を中栓体(3)の前端と重なり合って適合するように凹状に陥没させて形成した請求項1又は2のいずれかに記載のプレフィルドシリンジ。 The plug body that partitions the front chamber (6) and the rear chamber (7) is the middle plug body (3), and is moved in front of the front chamber (6) by being pressurized by the forward movement of the middle plug body (3). By providing the front plug body (2) for discharging the solution of the first component (14) and the second component (16) to the outside of the main body (1), the front end face of the inner plug body (3) is shaped like a mountain. project was formed on, according to any of the previous plug body (2) rear surface Chusentai (3) according to claim 1 or 2 was formed by recessed concave to fit overlap the front end of the Prefilled syringe.
JP2016226677A 2016-11-22 2016-11-22 Prefilled syringe Active JP6294440B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2016226677A JP6294440B1 (en) 2016-11-22 2016-11-22 Prefilled syringe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2016226677A JP6294440B1 (en) 2016-11-22 2016-11-22 Prefilled syringe

Publications (2)

Publication Number Publication Date
JP6294440B1 true JP6294440B1 (en) 2018-03-14
JP2018082796A JP2018082796A (en) 2018-05-31

Family

ID=61628983

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016226677A Active JP6294440B1 (en) 2016-11-22 2016-11-22 Prefilled syringe

Country Status (1)

Country Link
JP (1) JP6294440B1 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2022047173A (en) * 2020-09-11 2022-03-24 ニプロ株式会社 Pre-filled syringe

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06142203A (en) * 1992-04-30 1994-05-24 Takeda Chem Ind Ltd Prefilled syringe
JPH07299141A (en) * 1994-02-18 1995-11-14 Takeda Chem Ind Ltd Refilled syringe
JP2010540122A (en) * 2007-09-27 2010-12-24 ベクトン・ディキンソン・アンド・カンパニー Cartridge for powder and liquid drugs

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06142203A (en) * 1992-04-30 1994-05-24 Takeda Chem Ind Ltd Prefilled syringe
JPH07299141A (en) * 1994-02-18 1995-11-14 Takeda Chem Ind Ltd Refilled syringe
JP2010540122A (en) * 2007-09-27 2010-12-24 ベクトン・ディキンソン・アンド・カンパニー Cartridge for powder and liquid drugs

Also Published As

Publication number Publication date
JP2018082796A (en) 2018-05-31

Similar Documents

Publication Publication Date Title
JP4682850B2 (en) Prefilled syringe
US7011650B2 (en) Multiple-dose syringe with collapsible container
US10112018B2 (en) Injector apparatus
US3986645A (en) Liquid dispenser
EP0588148B1 (en) Syringe having needle isolation features
US3291128A (en) Hypodermic syringe construction with sealable vent means
US9943648B2 (en) Closure piece for a powder syringe, and powder syringe
US4465476A (en) Injection syringe for injecting two liquids
JP2007185319A5 (en)
SE438095B (en) SPRAY AND TALKER FOR SUCH SPRAY
CN102753275B (en) Discharge device having a locking element
EP3603710B1 (en) Syringe type liquid ejection device
EP2461912B1 (en) Dispensing device with pressure release
JP6710639B2 (en) Ejector
EP2889016B1 (en) Dental syringe
WO2015079874A1 (en) Prefilled syringe
JP6294440B1 (en) Prefilled syringe
US3135260A (en) Plastic syringe
JP6384838B2 (en) Plunger for drug cartridge
EP1913966A1 (en) Combined container-syringe
EP3104911B1 (en) Syringe
JP4827175B2 (en) Two-chamber container and syringe
US1816857A (en) Syringe cartridge
JP2008104776A (en) Container-cum-syringe
JP7251762B2 (en) Needle-free injection device equipped with improved injection nozzle

Legal Events

Date Code Title Description
TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20180116

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20180215

R150 Certificate of patent or registration of utility model

Ref document number: 6294440

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250